These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Bone marrow function test in patients with chronic liver diseases. A contribution to the problem of hypersplenism]. Weinreich J Acta Hepatosplenol; 1969; 16(1):18-24. PubMed ID: 5800605 [No Abstract] [Full Text] [Related]
4. [Enterohepatic circulation values and erythrocyte aging in patients with liver cirrhosis]. Paumgartner G; Richter H; Brunner H; Lauringer P; Grabner G Wien Z Inn Med; 1970 Jun; 51(6):278-80. PubMed ID: 5521934 [No Abstract] [Full Text] [Related]
5. [Beta-lipoprotein lipids of the human serum in liver diseases. I. Variations in the relative quantity of triglycerides]. Lukesová M; Lukes J Cas Lek Cesk; 1970 Apr; 109(19):424-8. PubMed ID: 5444773 [No Abstract] [Full Text] [Related]
6. [Erythrocyte life span in patients with chronic nonspecific diseases of the lungs]. Tarasov AN Ter Arkh; 1970 Sep; 42(9):59-61. PubMed ID: 5502193 [No Abstract] [Full Text] [Related]
7. [Beta-lipoprotein lipids of the human serum in liver diseases. II. Variations in the relative quantity of phospholipids]. Lukesová M; Lukes J Cas Lek Cesk; 1970 May; 109(21):466-70. PubMed ID: 5444503 [No Abstract] [Full Text] [Related]
8. [Length of the life of erythrocytes in liver cirrhosis and its relation with blood indicators]. Sokolova GM Ter Arkh; 1972 Nov; 44(11):99-102. PubMed ID: 4666040 [No Abstract] [Full Text] [Related]
9. [Study of the life-span of erythrocytes labeled with Cr51 in patients with chronic hepatitis or splenomegalic cirrhosis]. Gheorghescu B; Merculiev E; Timiş E; Mardale D; Dan M Med Interna (Bucur); 1966 Jun; 18(6):711-9. PubMed ID: 5965384 [No Abstract] [Full Text] [Related]
13. [Study of total insulin activity and the content of free insulin in the blood in chronic diffuse liver diseases]. Rostomova LT; Kurashvili RB Ter Arkh; 1974; 46(12):87-90. PubMed ID: 4454029 [No Abstract] [Full Text] [Related]
15. [Fasting and postprandial serum bile acids in chronic liver diseases]. Testa R; Dellepiane F; Rovida S; Lapertosa G; Domina AR; Virdis MG; Risso D; Mansi C; Picciotto A; Savarino V; Celle G Minerva Dietol Gastroenterol; 1982; 28(3):195-200. PubMed ID: 7145170 [No Abstract] [Full Text] [Related]
16. [Complement activity in chronic liver diseases]. Ghidini O; Del Campo A; Tomasi A; Franzoni A G Clin Med; 1970 Jul; 51(7):568-79. PubMed ID: 5527274 [No Abstract] [Full Text] [Related]
17. [Chromatographic determination of plasma and erythrocyte phospholipids in a group of patients with liver diseases]. Ferlito S; Fichera C; Terranova R Minerva Gastroenterol; 1973; 19(4):207-15. PubMed ID: 4781112 [No Abstract] [Full Text] [Related]
18. [Conjugated serum bile acids in chronic liver diseases and cholestasis]. Frosch B; Wagener H Acta Hepatosplenol; 1971; 18(4):273-86. PubMed ID: 5110093 [No Abstract] [Full Text] [Related]
19. [Diagnostic value of serum bile acids in chronic diseases of the liver]. Testa R; Bocchini R; Dellepiane F; Dodero M; Celle G Med Chir Dig; 1980; 9(2):95-7. PubMed ID: 7401731 [No Abstract] [Full Text] [Related]
20. Blood ammonia in portal hypertension and liver diseases in children. Michalowicz-Wojczyńska E Pol Med J; 1969; 8(5):1101-10. PubMed ID: 5310033 [No Abstract] [Full Text] [Related] [Next] [New Search]